Obesity is associated with the development of leptin resistance. However, the effects of leptin resistance on leptin-regulated metabolic processes and the biochemical defects that cause leptin resistance are poorly understood. We have addressed in rats the effect of dietinduced obesity (DIO), a situation of elevated tissue lipid levels, on the well described lipid-lowering effect of leptin in liver, an action that is proposed to be important for the prevention of tissue lipotoxicity and insulin resistance. In addition, we have addressed the role of phosphatidylinositol 3-kinase (PI 3-kinase) in mediating the acute effects of leptin on hepatic lipid levels in lean and DIO animals. A 90-min leptin (ϳ10 ng/ml) perfusion of isolated livers from lean animals decreased triglyceride levels by 42 ؎ 5% (p ؍ 0.006). However, leptin concentrations ranging from ϳ10 to ϳ90 ng/ml had no effect on triglyceride levels in livers from DIO animals. The acute lipid-lowering effect of leptin on livers from lean animals was mediated by a PI 3-kinase-dependent mechanism, because wortmannin and LY294002, the PI 3-kinase inhibitors, blocked the effects of leptin on hepatic triglyceride levels and leptin increased liver PI 3-kinase activity by 183 ؎ 6% (p ؍ 0.003) and insulin receptor substrate 1 tyrosine phosphorylation by 185 ؎ 30% (p ؍ 0.02) in the absence of PI 3-kinase inhibitors. Contrary to the effects of leptin in lean livers, leptin did not activate PI 3-kinase in livers from DIO rats. These data present evidence for a role for 1) leptin resistance in contributing to the excessive accumulation of tissue lipid in obesity, 2) PI 3-kinase in mediating the acute lipid-lowering effects of leptin in liver, and 3) defective leptin activation of PI 3-kinase as a novel mechanism of leptin resistance.Human obesity and diet-induced obesity in rodents are associated with the development of leptin resistance (1-3). However, despite substantial progress, our understanding of the consequences of leptin resistance for the metabolic actions of leptin and the molecular defects causing leptin resistance remains vague. Metabolic abnormalities arising from defective leptin action are most clear in leptin-deficient states caused by leptin gene mutations or lipodystrophy in humans or rodents. These states are characterized by hyperlipidemia, excessive storage of lipid in tissues such as liver and skeletal muscle, and insulin resistance, defects that are markedly improved by administration of leptin (4 -8). Similar effects on lipid metabolism and/or insulin sensitivity are obtained in normal rodents with acute (9, 10) or prolonged (11-13) hyperleptinemia. In the ZDF rat characterized by non-functional leptin receptors and obesity, elevated hepatic lipid levels are reduced by adenovirusmediated expression of functional wild-type leptin receptors in liver (14), whereas administration of leptin to gold-thioglucosetreated mice that lack hypothalamic leptin function decreases hepatic lipogenesis (15). Taken together, these studies demonstrate potent l...